Beijing Leadman Biochemistry Co Ltd Cash Flow Reinvestment Rate
Beijing Leadman Biochemistry Co Ltd cash flow reinvestment rate. Beijing Leadman Biochemistry Co Ltd (300289) has a Cash Flow Reinvestment Rate of 0.12x as of September 2025, reinvesting CN¥1.40 Million (capex CN¥1.40 Million ) from operating cash flow of CN¥11.89 Million. Explore Beijing Leadman Biochemistry Co Ltd (300289) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Beijing Leadman Biochemistry Co Ltd (2008–2025)
Cash flow reinvestment rate of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. Historical reinvestment intensity for Beijing Leadman Biochemistry Co Ltd across 17 annual periods. Explore Beijing Leadman Biochemistry Co Ltd (300289) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Beijing Leadman Biochemistry Co Ltd Cash Flow Reinvestment Rate by Year (2008–2025)
Beijing Leadman Biochemistry Co Ltd cash flow reinvestment rate by year from 2008 to 2025. Year-by-year capital reinvestment analysis for Beijing Leadman Biochemistry Co Ltd. For the full cash flow conversion analysis, see 300289 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.62x | CN¥76.49 Million | CN¥29.16 Million | CN¥17.59 Million | ▲ +318.5% |
| 2024 | 0.63x | CN¥39.11 Million | CN¥62.41 Million | CN¥29.23 Million | ▼ -76.2% |
| 2023 | 2.63x | CN¥353.33 Million | CN¥134.42 Million | CN¥18.69 Million | ▲ +13.5% |
| 2022 | 2.32x | CN¥252.23 Million | CN¥108.93 Million | CN¥39.12 Million | ▲ +217.5% |
| 2021 | 0.73x | CN¥86.83 Million | CN¥119.06 Million | CN¥44.50 Million | ▲ +243.7% |
| 2020 | 0.21x | CN¥28.77 Million | CN¥135.56 Million | CN¥28.39 Million | ▼ -11.9% |
| 2019 | 0.24x | CN¥30.03 Million | CN¥124.65 Million | CN¥26.28 Million | ▲ +6.8% |
| 2018 | 0.23x | CN¥18.27 Million | CN¥81.02 Million | CN¥12.24 Million | ▲ +61.1% |
| 2017 | 0.14x | CN¥16.93 Million | CN¥120.97 Million | CN¥10.90 Million | ▼ -61.0% |
| 2016 | 0.36x | CN¥29.34 Million | CN¥81.78 Million | CN¥23.31 Million | ▲ +107.4% |
| 2015 | 0.17x | CN¥30.75 Million | CN¥177.82 Million | CN¥24.72 Million | ▼ -89.8% |
| 2013 | 1.70x | CN¥153.34 Million | CN¥90.45 Million | CN¥153.34 Million | ▼ -59.5% |
| 2012 | 4.19x | CN¥242.17 Million | CN¥57.86 Million | CN¥242.17 Million | ▲ +8.2% |
| 2011 | 3.87x | CN¥113.50 Million | CN¥29.34 Million | CN¥113.50 Million | ▲ +435.3% |
| 2010 | 0.72x | CN¥38.63 Million | CN¥53.46 Million | CN¥38.63 Million | ▲ +49.9% |
| 2009 | 0.48x | CN¥15.06 Million | CN¥31.26 Million | CN¥15.06 Million | ▲ +75.3% |
| 2008 | 0.27x | CN¥6.04 Million | CN¥21.98 Million | CN¥6.04 Million | — |